Logo image of EPSN

EPSILON ENERGY LTD (EPSN) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EPSN - CA2943752097 - Common Stock

4.43 USD
+0.03 (+0.68%)
Last: 1/15/2026, 10:16:59 AM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EPSN. EPSN was compared to 208 industry peers in the Oil, Gas & Consumable Fuels industry. EPSN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. EPSN is cheap, but on the other hand it scores bad on growth. This makes EPSN very considerable for value investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • EPSN had positive earnings in the past year.
  • EPSN had a positive operating cash flow in the past year.
  • In the past 5 years EPSN has always been profitable.
  • Each year in the past 5 years EPSN had a positive operating cash flow.
EPSN Yearly Net Income VS EBIT VS OCF VS FCFEPSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • EPSN has a Return On Assets of 4.66%. This is in the better half of the industry: EPSN outperforms 64.42% of its industry peers.
  • The Return On Equity of EPSN (5.87%) is comparable to the rest of the industry.
  • EPSN's Return On Invested Capital of 7.03% is fine compared to the rest of the industry. EPSN outperforms 63.46% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EPSN is significantly below the industry average of 21.83%.
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROIC 7.03%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
EPSN Yearly ROA, ROE, ROICEPSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • EPSN has a Profit Margin of 12.86%. This is in the better half of the industry: EPSN outperforms 63.94% of its industry peers.
  • EPSN's Profit Margin has declined in the last couple of years.
  • EPSN's Operating Margin of 29.19% is fine compared to the rest of the industry. EPSN outperforms 71.15% of its industry peers.
  • EPSN's Operating Margin has declined in the last couple of years.
  • EPSN has a better Gross Margin (74.48%) than 86.06% of its industry peers.
  • EPSN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
EPSN Yearly Profit, Operating, Gross MarginsEPSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

7

2. Health

2.1 Basic Checks

  • EPSN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, EPSN has less shares outstanding
  • The number of shares outstanding for EPSN has been reduced compared to 5 years ago.
  • EPSN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
EPSN Yearly Shares OutstandingEPSN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
EPSN Yearly Total Debt VS Total AssetsEPSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • EPSN has an Altman-Z score of 2.83. This is not the best score and indicates that EPSN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of EPSN (2.83) is better than 79.33% of its industry peers.
  • There is no outstanding debt for EPSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.83
ROIC/WACC0.8
WACC8.82%
EPSN Yearly LT Debt VS Equity VS FCFEPSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 1.93 indicates that EPSN should not have too much problems paying its short term obligations.
  • EPSN has a Current ratio of 1.93. This is in the better half of the industry: EPSN outperforms 75.96% of its industry peers.
  • EPSN has a Quick Ratio of 1.93. This is a normal value and indicates that EPSN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of EPSN (1.93) is better than 78.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
EPSN Yearly Current Assets VS Current LiabilitesEPSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

3

3. Growth

3.1 Past

  • EPSN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.00%, which is quite impressive.
  • Measured over the past years, EPSN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -22.77% on average per year.
  • EPSN shows a strong growth in Revenue. In the last year, the Revenue has grown by 46.76%.
  • Measured over the past years, EPSN shows a small growth in Revenue. The Revenue has been growing by 3.38% on average per year.
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPSN Yearly Revenue VS EstimatesEPSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
EPSN Yearly EPS VS EstimatesEPSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2020 2023 2024 2025 0 0.1 0.2 0.3 0.4

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.04, the valuation of EPSN can be described as reasonable.
  • 84.13% of the companies in the same industry are more expensive than EPSN, based on the Price/Earnings ratio.
  • EPSN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.33.
  • A Price/Forward Earnings ratio of 9.05 indicates a reasonable valuation of EPSN.
  • Based on the Price/Forward Earnings ratio, EPSN is valued cheaper than 82.69% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.12, EPSN is valued rather cheaply.
Industry RankSector Rank
PE 9.04
Fwd PE 9.05
EPSN Price Earnings VS Forward Price EarningsEPSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EPSN indicates a rather cheap valuation: EPSN is cheaper than 86.06% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, EPSN is valued a bit cheaper than the industry average as 76.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.84
EV/EBITDA 3.67
EPSN Per share dataEPSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • EPSN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of EPSN may justify a higher PE ratio.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

  • EPSN has a Yearly Dividend Yield of 5.72%, which is a nice return.
  • EPSN's Dividend Yield is a higher than the industry average which is at 3.91.
  • Compared to an average S&P500 Dividend Yield of 1.91, EPSN pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.72%

5.2 History

  • EPSN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
EPSN Yearly Dividends per shareEPSN Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • 93.55% of the earnings are spent on dividend by EPSN. This is not a sustainable payout ratio.
DP93.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPSN Yearly Income VS Free CF VS DividendEPSN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M
EPSN Dividend Payout.EPSN Dividend Payout, showing the Payout Ratio.EPSN Dividend Payout.PayoutRetained Earnings

EPSILON ENERGY LTD

NASDAQ:EPSN (1/15/2026, 10:16:59 AM)

4.43

+0.03 (+0.68%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-05
Earnings (Next)03-17
Inst Owners61.36%
Inst Owner Change0%
Ins Owners6.94%
Ins Owner Change0.43%
Market Cap107.65M
Revenue(TTM)45.71M
Net Income(TTM)5.88M
Analysts82.86
Price Target8.57 (93.45%)
Short Float %3.42%
Short Ratio4.55
Dividend
Industry RankSector Rank
Dividend Yield 5.72%
Yearly Dividend0.25
Dividend Growth(5Y)N/A
DP93.55%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)163.48%
Min EPS beat(2)132.84%
Max EPS beat(2)194.12%
EPS beat(4)3
Avg EPS beat(4)77.96%
Min EPS beat(4)-41.18%
Max EPS beat(4)194.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.62%
Min Revenue beat(2)-23.45%
Max Revenue beat(2)-3.78%
Revenue beat(4)1
Avg Revenue beat(4)1.29%
Min Revenue beat(4)-23.45%
Max Revenue beat(4)35.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.04
Fwd PE 9.05
P/S 2.36
P/FCF 10.84
P/OCF 4.16
P/B 1.07
P/tB 1.07
EV/EBITDA 3.67
EPS(TTM)0.49
EY11.06%
EPS(NY)0.49
Fwd EY11.05%
FCF(TTM)0.41
FCFY9.23%
OCF(TTM)1.07
OCFY24.07%
SpS1.88
BVpS4.12
TBVpS4.12
PEG (NY)0.04
PEG (5Y)N/A
Graham Number6.74
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 5.87%
ROCE 11.46%
ROIC 7.03%
ROICexc 7.9%
ROICexgc 7.9%
OM 29.19%
PM (TTM) 12.86%
GM 74.48%
FCFM 21.73%
ROA(3y)11.91%
ROA(5y)9.69%
ROE(3y)14.27%
ROE(5y)11.75%
ROIC(3y)10.21%
ROIC(5y)8.94%
ROICexc(3y)15.79%
ROICexc(5y)13.41%
ROICexgc(3y)15.79%
ROICexgc(5y)13.41%
ROCE(3y)16.64%
ROCE(5y)14.58%
ROICexgc growth 3Y-47.2%
ROICexgc growth 5Y-12.62%
ROICexc growth 3Y-47.2%
ROICexc growth 5Y-12.62%
OM growth 3Y-31.37%
OM growth 5Y-9.53%
PM growth 3Y-39.36%
PM growth 5Y-28.44%
GM growth 3Y-4.33%
GM growth 5Y-0.17%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 129.79%
Cap/Sales 34.94%
Interest Coverage 1347.55
Cash Conversion 101.01%
Profit Quality 168.97%
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 2.83
F-Score7
WACC8.82%
ROIC/WACC0.8
Cap/Depr(3y)242.3%
Cap/Depr(5y)173.79%
Cap/Sales(3y)62.73%
Cap/Sales(5y)45.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96%
EPS 3Y-43.6%
EPS 5Y-22.77%
EPS Q2Q%350%
EPS Next Y206%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)46.76%
Revenue growth 3Y-9.41%
Revenue growth 5Y3.38%
Sales Q2Q%23.22%
Revenue Next Year38.2%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y195.55%
EBIT growth 3Y-37.82%
EBIT growth 5Y-6.47%
EBIT Next Year539.19%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y106.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.88%
OCF growth 3Y-5.61%
OCF growth 5Y5.32%

EPSILON ENERGY LTD / EPSN FAQ

What is the ChartMill fundamental rating of EPSILON ENERGY LTD (EPSN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EPSN.


What is the valuation status for EPSN stock?

ChartMill assigns a valuation rating of 8 / 10 to EPSILON ENERGY LTD (EPSN). This can be considered as Undervalued.


How profitable is EPSILON ENERGY LTD (EPSN) stock?

EPSILON ENERGY LTD (EPSN) has a profitability rating of 6 / 10.


How financially healthy is EPSILON ENERGY LTD?

The financial health rating of EPSILON ENERGY LTD (EPSN) is 8 / 10.


What is the earnings growth outlook for EPSILON ENERGY LTD?

The Earnings per Share (EPS) of EPSILON ENERGY LTD (EPSN) is expected to grow by 206% in the next year.